Health Care: Drugs

Opexa Therapeutics Inc (OPXA: NASDAQ)

$1.53 -0.04 | -2.55%
07/31/14 - 04:00 PM ET
Ratio Comparisons
Company Industry S&P 500
Valuation Ratios
P/E Ratio (TTM) n.a. n.a. 28.90
P/E High - Last 5 Yrs n.a. n.a. 42.71
P/E Low - Last 5 Yrs n.a. n.a. 9.54
Beta 2.70 0.95 1.09
Price to Sales (TTM) 31.12 10.27 2.86
Price to Book (MRQ) 2.50 7.90 4.69
Price to Tangible Book (MRQ) 2.50 33.68 7.78
Price to Cash Flow (TTM) -2.80 73.90 18.91
Price to Free Cash Flow (TTM) -3.20 -54.40 18.59
Dividends
Dividend Yield (%) 0.00 0.40 1.84
Dividend Yield - 5 Yr Avg (%) n.a. 0.20 2.44
Dividend 5 Yr Growth Rate (%) n.a. 31.86 13.01
Payout Ratio (TTM) 0.00 n.a. 45.52
Sales (MRQ) vs Qtr 1 Yr Ago (%) 58.50 41.90 6.75
Sales (TTM) vs TTM 1 Yr Ago (%) n.a. 16.10 5.54
Growth Rates (%)
Sales - 5 Yr Growth Rate (%) n.a. 6.16 6.92
EPS (MRQ) vs Qtr 1 Yr Ago (%) n.a. 64.70 74.07
EPS (TTM) vs TTM 1 Yr Ago (%) n.a. 64.70 74.07
EPS - 5 Yr Growth Rate (%) n.a. n.a. 10.79
Capital Spending - 5 Yr Growth Rate (%) n.a. 23.13 9.77
Financial Strength
Quick Ratio (MRQ) 5.90 2.60 1.27
Current Ratio (MRQ) 6.40 3.10 1.93
LT Debt to Equity (MRQ) 0.00 0.59 1.01
Total Debt to Equity (MRQ) 0.00 0.68 1.16
Interest Coverage (TTM) n.a. 5.60 53.55
Profitability Ratios (%)
Gross Margin (TTM) n.a. 87.70 47.39
Gross Margin - 5 Yr Avg n.a. 85.90 46.66
EBITD Margin (TTM) n.a. 22.90 25.43
EBITD - 5 Yr Avg -6,635.76 0.00 0.00
Pre-Tax Margin (TTM) n.a. 13.00 15.55
Pre-Tax Margin - 5 Yr Avg n.a. 14.20 13.85
Management Effectiveness (%)
Net Profit Margin (TTM) 0.00 7.61 9.21
Net Profit Margin - 5 Yr Avg n.a. 9.70 10.59
Return on Assets (TTM) -71.10 2.40 6.83
Return on Assets - 5 Yr Avg -73.00 3.90 6.45
Return on Investment (TTM) -93.00 3.20 12.50
Return on Investment - 5 Yr Avg -88.60 5.20 11.06
Efficiency
Revenue/Employee (TTM) 36,720.00 798,948.00 943,179.12
Net Income/Employee (TTM) -424,590.00 53,376.00 113,397.73
Receivable Turnover (TTM) n.a. 5.90 14.76
Inventory Turnover (TTM) 0.00 1.10 19.92
Asset Turnover (TTM) 0.10 0.40 0.80

Portfolios with OPXA

Latest OPXA Headlines from TheStreet

More Financial News for OPXA

Press Releases for OPXA

See All Press Releases

Partner Headlines for OPXA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter